...[[sitagliptin/metformin/ja|シタグリプチン/メトホルミン]]（ジャヌメット、ジャヌメットXR）と[[sitagliptin/simvastatin/ja|シタグリプチン/シンバスタチン]]（ジュビシンク）の[[fixed-dose combination/ja|合剤]]としても利用できる。
...し、米国ではジャヌメットの商品名で販売されている。2011年10月7日、FDAは米国でJuvisyncとして販売されている[[sitagliptin/simvastatin/ja|シタグリプチン/シンバスタチン]]の経口配合剤を承認した。
...
10 KB (637 words) - 22:17, 12 March 2024
...on]]s of [[sitagliptin/metformin]] (Janumet, Janumet XR) and [[sitagliptin/simvastatin]] (Juvisync).
...On October 7, 2011, the FDA approved an oral combination of [[sitagliptin/simvastatin]] marketed in the US as Juvisync.
...
8 KB (1,202 words) - 20:17, 12 March 2024
...on]]s of [[sitagliptin/metformin]] (Janumet, Janumet XR) and [[sitagliptin/simvastatin]] (Juvisync).
...On October 7, 2011, the FDA approved an oral combination of [[sitagliptin/simvastatin]] marketed in the US as Juvisync.
...
9 KB (1,250 words) - 20:17, 12 March 2024
...the biosynthesis of cholesterol and they include atorvastatin, lovastatin, simvastatin, rosuvastatin, pravastatin, fluvastatin, and pitavastatin. These agents wor
...sease saw a reduction in vascular and major atherosclerotic events when on simvastatin and ezetimibe compared to placebo. This same combination was also shown to
...
15 KB (2,054 words) - 17:52, 13 April 2024
...the biosynthesis of cholesterol and they include atorvastatin, lovastatin, simvastatin, rosuvastatin, pravastatin, fluvastatin, and pitavastatin. These agents wor
...sease saw a reduction in vascular and major atherosclerotic events when on simvastatin and ezetimibe compared to placebo. This same combination was also shown to
...
16 KB (2,114 words) - 17:52, 13 April 2024
...A reductase]], such as lovastatin, atorvastatin, fluvastatin, pravastatin, simvastatin, rosuvastatin, and pitavastatin, inhibit the synthesis of [[mevalonate]], a
...
22 KB (2,903 words) - 17:19, 13 April 2024
...[[lovastatin|lovastatin]], [[pravastatin|pravastatin]], and [[simvastatin|simvastatin]]
...tin), the second available in the United States, and the release of Zocor (simvastatin) made Mevacor no longer the only statin on the market.
...
52 KB (6,923 words) - 17:09, 5 November 2023
...A reductase]], such as lovastatin, atorvastatin, fluvastatin, pravastatin, simvastatin, rosuvastatin, and pitavastatin, inhibit the synthesis of [[mevalonate]], a
...
23 KB (3,017 words) - 17:18, 13 April 2024
...[[lovastatin|lovastatin]], [[pravastatin|pravastatin]], and [[simvastatin|simvastatin]]
...tin), the second available in the United States, and the release of Zocor (simvastatin) made Mevacor no longer the only statin on the market.
...
54 KB (7,245 words) - 17:08, 5 November 2023
徐放性ナイアシンは[[lovastatin/ja|ロバスタチン]]（アドビコール）、および[[simvastatin/ja|シンバスタチン]]（シムコール）と処方薬物として併用された。ナイアシン/ロバスタチンの併用は2001年に米国[[Food and Drug Ad
...
55 KB (2,081 words) - 15:30, 20 February 2024
# [[Statin|スタチン]]: [[lovastatin/ja|ロバスタチン]], [[pravastatin/ja|プラバスタチン]], [[simvastatin|シンバスタチン]]
...
58 KB (1,845 words) - 17:09, 5 November 2023
....S. [[Food and Drug Administration]] (FDA) in 2001. The combination niacin/simvastatin was approved by the FDA in 2008. Subsequently, large outcome trials using t
...
44 KB (6,139 words) - 15:30, 20 February 2024
....S. [[Food and Drug Administration]] (FDA) in 2001. The combination niacin/simvastatin was approved by the FDA in 2008. Subsequently, large outcome trials using t
...
45 KB (6,281 words) - 15:29, 20 February 2024
...inavian Simvastatin Survival Study]], were announced. Researchers tested [[simvastatin]], later sold by Merck as Zocor, on 4,444 patients with high cholesterol an
...
60 KB (8,551 words) - 22:13, 8 January 2023